CAR T-Cell Therapy; Myeloma Center; Winthrop P. Rockefeller Cancer Institute; Chimeric antigen receptor (CAR) T-cell therapy; Frits van Rhee

August 9, 2021

UAMS Offering Revolutionary CAR T-Cell Therapy for Myeloma Patients

Linda Haymes

“This offers an entirely new treatment option for relapsed myeloma patients,” said Myeloma Center clinical director Frits van Rhee, M.D., Ph.D. “It is a whole new class of treatment; it’s like immunotherapy is coming of age.”

The Myeloma Center at the UAMS Winthrop P. Rockefeller Cancer Institute is offering a new cutting-edge immunotherapy treatment for myeloma patients. The University of Arkansas for Medical Sciences (UAMS) is the first and only medical facility in Arkansas approved to provide cellular therapy to myeloma patients.